It’s Hard to Get Meds to the Lungs: Breathable Algae Offer a New Path
|
Researchers have engineered inhalable algae-based microrobots that can deliver drugs deep into the lungs. Moores members Joseph Wang, DSc, and Liangfang Zhang, PhD, touch on how these microrobots offer promising new methods for targeting lung diseases, including tumors. Learn More>>
|
Moores Member Elected to Association of American Physicians (AAP)
|
Harold (Hal) Hoffman, MD, was selected for membership to the AAP for his contributions to basic and translational biomedical research. As a leading expert in rare pediatric diseases, Dr. Hoffman specializes in the care of children with rare inflammatory and immunologic disorders. Learn More>>
|
|
|
MOORES CANCER CENTER AT ASCO |
At the ASCO Annual Meeting 2025, taking place from May 30 — June 3 in Chicago, IL, our physician-scientists will present key findings on machine learning's role in trial design, GIST treatment breakthroughs, renal cell therapies and more.
|
Science in Session: Aditya Bagrodia, MD, FACS
|
Learn more about Dr. Bagrodia's role as a chair of an educational session focusing on refining the treatment of germ-cell tumors, and aspects of survival and survivorship for young cancer patients.
|
|
|
|
|
Spatial-Temporal Diversity of Extrachromosomal DNA Shapes Urothelial Carcinoma Evolution and the Tumor Immune Microenvironment |
Vineet Bafna, PhD (Structural and Functional Genomics)
|
|
|
| The inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell-mediated transplant rejection
|
Science Translational Medicine
|
Enfu Hui, PhD (Hematologic Malignancies)
|
|
|
| HRProfiler Detects Homologous Recombination Deficiency in Breast and Ovarian Cancers Using Whole-Genome and Whole-Exome Sequencing Data
|
Erik N. Bergstrom, PhD (Structural and Functional Genomics [SFG]), Rana R. McKay, MD (Solid Tumor Therapeutics) and Ludmil B. Alexandrov, PhD (SFG)
|
|
|
FEATURED FUNDING OPPORTUNITIES
|
The Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP), Rare Cancers Research Program (RCRP) has released program announcements for the following funding opportunities . Learn More>>
|
- Concept Award
- Idea Development Award
- Resource and Community Development Award
|
|
|
CLINICAL TRIALS OFFICE (CTO)
|
ENV-ONC-501: A First-in-Human, Open-label, Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ENV501 in Patients with Advanced-Stage, Relapsed/Refractory HER3Expressing Solid Tumors
PI: Rebecca Shatsky, MD
NCT ID: NCT06956690
ACE2016-001: A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ACE2016, an Allogeneic Anti-EGFR Conjugated Gamma Delta T Cell (gd-T) Therapy in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
PI: Sandip Patel, MD
NCT ID: NCT06415487
CA0711000: A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS986365 versus Investigators Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) rechARge
PI: Rana McKay, MD
NCT ID: NCT06764485
GI008: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PI: Gregory Botta, MD, PhD
NCT ID: NCT05174169
PRISM-1: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma
PI: Gregory Botta, MD, PhD
NCT ID: NCT06608927
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
Bridging the Gap: Women's Health and Advocacy Luncheon
|
In celebration of Women's Health Month, the Community Outreach and Engagement team, in collaboration with the Black Infant Health Program, hosted a special luncheon event. The program emphasized patient advocacy, mental health, and highlighted available programs and resources tailored especially for Black women. Free massages and health screenings were offered to attendees, enhancing the focus on holistic well-being. This impactful event was made possible through the valuable contributions of presenters and exhibitors who shared their expertise and support. The luncheon fostered awareness and empowerment around women's health, addressing the unique needs of Black women in the community.
|
|
| |
